Protooncogene junB as a target for activin actions.

Hashimoto, M; Gaddy-Kurten, D; Vale, W

Hashimoto, M; Gaddy-Kurten, D; Vale, W.

Affiliation

Hashimoto M; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, La Jolla, California 92037-1099.

Endocrinology ; 133(5): 1934-40, 1993 Nov.

Article in En | MEDLINE | ID: mdl-8404639

Subject(s)

Gene Expression Regulation, Neoplastic/drug effects; Genes, jun/drug effects; Inhibins/pharmacology; Activins; Animals; Drug Synergism; Genes, Immediate-Early; Humans; Kinetics; Leukemia, Myeloid; PC12 Cells; Protein Kinase C/metabolism; RNA, Messenger/biosynthesis; Rats; Tetradecanoylphorbol Acetate/pharmacology; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Genes, jun / Inhibins Type of study: Prognostic_studies Language: En Journal: Endocrinology Year: 1993 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links